ID: ALA2442775

Max Phase: Preclinical

Molecular Formula: C12H25NO3

Molecular Weight: 231.34

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCCCC[C@H]1N[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C12H25NO3/c1-3-4-5-6-7-9-11(15)12(16)10(14)8(2)13-9/h8-16H,3-7H2,1-2H3/t8-,9+,10+,11+,12+/m0/s1

Standard InChI Key:  HSOPYIWJVCVZBS-VSSNEEPJSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 231.34

Molecular Weight (Monoisotopic): 231.1834

AlogP: 0.40

#Rotatable Bonds: 5

Polar Surface Area: 72.72

Molecular Species: BASE

HBA: 4

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 12.89

CX Basic pKa: 8.90

CX LogP: 0.88

CX LogD: -0.63

Aromatic Rings: 0

Heavy Atoms: 16

QED Weighted: 0.52

Np Likeness Score: 1.95

References

1. Kato A, Okaki T, Ifuku S, Sato K, Hirokami Y, Iwaki R, Kamori A, Nakagawa S, Adachi I, Kiria PG, Onomura O, Minato D, Sugimoto K, Matsuya Y, Toyooka N..  (2013)  Synthesis and biological evaluation of N-(2-fluorophenyl)-2β-deoxyfuconojirimycin acetamide as a potent inhibitor for α-l-fucosidases.,  21  (21): [PMID:24026016] [10.1016/j.bmc.2013.08.028]

Source

Source(1):

• Scientific Literature